Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Castellano

Showing results (171-180 of 192) with videos related to

Pageof 20
Sort By:
Cancer Chemotherapy and Pharmacology|February 27, 2014
Phase II clinical trial of PM00104 (Zalypsis(®)) in urothelial carcinoma patients progressing after first-line platinum-based regimenDaniel E Castellano, Joaquim Bellmunt, José Pablo Maroto, et al.
Journal of Inorganic Biochemistry|April 2, 2023
Cytotoxic activity of Ru(II)/DPEPhos/N,S-mercapto complexes (DPEPhos = bis-[(2-diphenylphosphino)phenyl]ether)Gregory F Grawe, Katia M Oliveira, Celisnolia M Leite, et al.
Journal of Inorganic Biochemistry|March 22, 2021
New Al<sup>III</sup>Zn<sup>II</sup> and Al<sup>III</sup>Cu<sup>II</sup> dinuclear complexes: Phosphatase-like activity and cytotoxicityTiago P Camargo, José A F Oliveira, Thiago G Costa, et al.
Dalton Transactions (Cambridge, England : 2003)|September 27, 2019
Non-mutagenic Ru(ii) complexes: cytotoxicity, topoisomerase IB inhibition, DNA and HSA bindingMonize M da Silva, Mariana S de Camargo, Rodrigo S Correa, et al.
Macromolecular Bioscience|June 27, 2018
Design of Silica-Oligourethane-Collagen Membranes for Inflammatory Response Modulation: Characterization and Polarization of a Macrophage Cell LinePedro U Muñoz-González, Olivia Rivera-Debernardi, Birzabith Mendoza-Novelo, et al.
Biomedical Materials (Bristol, England)|April 28, 2022
Gel dressing based on type I collagen modified with oligourethane and silica for skin wound healingPedro U Muñoz-González, María C Lona-Ramos, Luis D Gutiérrez-Verdín, et al.
The Lancet. Oncology|October 22, 2011
Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective studyJesus Garcia-Donas, Emilio Esteban, Luis Javier Leandro-García, et al.
Clinical Genitourinary Cancer|April 16, 2022
Molecular Biomarkers of Prognosis in Advanced Renal Cell Carcinoma Patients Treated With Pazopanib Plus Interferon Alpha (INF-2A) in a Phase I/II Study by the Spanish Oncology Genitourinary GroupXavier García-Del-Muro, Ignacio Durán, Jose Luis Perez-Gracia, et al.
Journal of Inorganic Biochemistry|January 23, 2016
Ruthenium(II) complexes of 1,3-thiazolidine-2-thione: Cytotoxicity against tumor cells and anti-Trypanosoma cruzi activity enhanced upon combination with benznidazoleRodrigo S Corrêa, Monize M da Silva, Angelica E Graminha, et al.
Journal of Inorganic Biochemistry|November 4, 2004
The [Ru(Hedta)NO](0.1-) system: structure, chemical reactivity and biological assaysPatrícia Graça Zanichelli, Alexandre M Miotto, Heder F G Estrela, et al.
Pageof 20

Showing results (171-180 of 192) with videos related to

Sort By:
Pageof 20
Cancer Chemotherapy and Pharmacology|February 27, 2014
Phase II clinical trial of PM00104 (Zalypsis(®)) in urothelial carcinoma patients progressing after first-line platinum-based regimenDaniel E Castellano, Joaquim Bellmunt, José Pablo Maroto, et al.
Journal of Inorganic Biochemistry|April 2, 2023
Cytotoxic activity of Ru(II)/DPEPhos/N,S-mercapto complexes (DPEPhos = bis-[(2-diphenylphosphino)phenyl]ether)Gregory F Grawe, Katia M Oliveira, Celisnolia M Leite, et al.
Journal of Inorganic Biochemistry|March 22, 2021
New Al<sup>III</sup>Zn<sup>II</sup> and Al<sup>III</sup>Cu<sup>II</sup> dinuclear complexes: Phosphatase-like activity and cytotoxicityTiago P Camargo, José A F Oliveira, Thiago G Costa, et al.
Dalton Transactions (Cambridge, England : 2003)|September 27, 2019
Non-mutagenic Ru(ii) complexes: cytotoxicity, topoisomerase IB inhibition, DNA and HSA bindingMonize M da Silva, Mariana S de Camargo, Rodrigo S Correa, et al.
Macromolecular Bioscience|June 27, 2018
Design of Silica-Oligourethane-Collagen Membranes for Inflammatory Response Modulation: Characterization and Polarization of a Macrophage Cell LinePedro U Muñoz-González, Olivia Rivera-Debernardi, Birzabith Mendoza-Novelo, et al.
Biomedical Materials (Bristol, England)|April 28, 2022
Gel dressing based on type I collagen modified with oligourethane and silica for skin wound healingPedro U Muñoz-González, María C Lona-Ramos, Luis D Gutiérrez-Verdín, et al.
The Lancet. Oncology|October 22, 2011
Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective studyJesus Garcia-Donas, Emilio Esteban, Luis Javier Leandro-García, et al.
Clinical Genitourinary Cancer|April 16, 2022
Molecular Biomarkers of Prognosis in Advanced Renal Cell Carcinoma Patients Treated With Pazopanib Plus Interferon Alpha (INF-2A) in a Phase I/II Study by the Spanish Oncology Genitourinary GroupXavier García-Del-Muro, Ignacio Durán, Jose Luis Perez-Gracia, et al.
Journal of Inorganic Biochemistry|January 23, 2016
Ruthenium(II) complexes of 1,3-thiazolidine-2-thione: Cytotoxicity against tumor cells and anti-Trypanosoma cruzi activity enhanced upon combination with benznidazoleRodrigo S Corrêa, Monize M da Silva, Angelica E Graminha, et al.
Journal of Inorganic Biochemistry|November 4, 2004
The [Ru(Hedta)NO](0.1-) system: structure, chemical reactivity and biological assaysPatrícia Graça Zanichelli, Alexandre M Miotto, Heder F G Estrela, et al.
Pageof 20